ArticleInternational urogynecology journal2025
Gender-Affirming Vaginectomy with Concurrent Hysterectomy Compared to Staged Vaginectomy After Hysterectomy: A Cohort Study Analysis of 30-Day Perioperative Outcomes.
Article in International urogynecology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTo evaluate and compare 30-day perioperative outcomes of those undergoing gender-affirming vaginectomy with a hysterectomy and those with vaginectomy alone.
methodsThis was a retrospective cohort study of patients who underwent gender-affirming transvaginal vaginectomy with or without concurrent minimally invasive hysterectomy at an academic institution from 2020 to 2023 by surgeons in the division of Urogynecology and Reconstructive Pelvic Surgery. The primary outcome was a composite of clinically significant surgical complications within 30 days of the procedure, including Emergency Department (ED) visits, readmissions, re-operations, and surgical and urinary tract infections.
resultsSixty-eight patients underwent gender-affirming transvaginal vaginectomy during the study period. Thirty-one patients had vaginectomy at the time of concurrent hysterectomy, while 37 patients had staged vaginectomy following hysterectomy. The median age was 32.8 years (27.6-38.8), and the mean body mass index (BMI) was 28.5 (SD 0.7). All concurrent hysterectomies were performed laparoscopically. Most demographic characteristics were similar between the two groups, except that the staged vaginectomy group had a longer duration of hormone therapy and higher parity. No significant differences were observed in the 30-day perioperative complications between those who underwent combined procedure transvaginal vaginectomy with or without minimally invasive hysterectomy. The only notable differences were an increase in the median estimated blood loss and a longer operative time in the concurrent hysterectomy and vaginectomy group. However, no patients in the cohort required a blood transfusion, and there was no difference in the total length of hospital stay.
conclusionsConcurrently performing hysterectomy and vaginectomy adds no significant clinical morbidity to those undergoing vaginectomy as an interval procedure following hysterectomy.
Indexed as
Identifiers
40111470What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.